Clarus Therapeutics Hldgs Inc (CRXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRXT | TAK | ZTS | ONC | UTHR |
| Company | Clarus Therapeutics Hldgs Inc | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Beone Medicines Ltd | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.0650 | 18.55 | 128.93 | 318.66 | 503.70 |
| High | 0.0749 | 18.78 | 132.30 | 323.24 | 507.92 |
| Low | 0.0475 | 18.55 | 128.25 | 314.23 | 491.97 |
| Latest | 0.0475 | 18.75 | 131.10 | 316.99 | 503.90 |
| Change | -0.0215 | +0.22 | +1.34 | -5.38 | +0.30 |
| % Change | -31.16% | +1.19% | +1.03% | -1.67% | +0.06% |
| Volume | 2,737,100 | 2,145,100 | 5,546,400 | 364,100 | 610,200 |
| 20-Day Average Volume | 4,348,840 | 2,897,300 | 4,729,155 | 270,320 | 376,705 |
| Previous Close | 0.0690 | 18.53 | 129.76 | 322.37 | 503.60 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2088 | 18.20 | 127.22 | 349.62 | 482.23 |
| 20-Day Raw Stochastic | 0.00% | 96.06% | 89.74% | 4.73% | 55.71% |
| 20-Day Relative Strength | 26.48 | 72.74 | 57.80 | 40.19 | 56.86 |
| Weighted Alpha | -96.72 | +39.28 | -19.99 | +15.21 | +50.72 |
| Today's Opinion | 100% Sell | 100% Buy | 24% Sell | 24% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 24% Sell | 32% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 80% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -69.75% since 08/29/22 | +0.48% since 02/20/26 | +1.80% since 02/20/26 | -12.47% since 02/20/26 | +6.44% since 02/20/26 |
| Low | 0.0475 on 09/06/22 | 18.36 on 02/26/26 | 124.42 on 02/23/26 | 314.23 on 02/27/26 | 466.00 on 02/23/26 |
| High | 0.1400 on 08/30/22 | 18.82 on 02/23/26 | 132.30 on 02/27/26 | 372.73 on 02/24/26 | 537.19 on 02/25/26 |
| 1-Month | |||||
| %Chg | -84.34% since 08/05/22 | +10.88% since 01/27/26 | +4.91% since 01/27/26 | -5.70% since 01/27/26 | +5.69% since 01/27/26 |
| Low | 0.0475 on 09/06/22 | 16.63 on 01/28/26 | 118.94 on 02/12/26 | 314.23 on 02/27/26 | 462.02 on 01/30/26 |
| High | 0.3489 on 08/15/22 | 18.82 on 02/23/26 | 132.49 on 02/12/26 | 372.73 on 02/24/26 | 537.19 on 02/25/26 |
| 3-Month | |||||
| %Chg | -90.08% since 06/06/22 | +29.13% since 11/26/25 | +2.67% since 11/26/25 | -6.94% since 11/26/25 | +3.17% since 11/26/25 |
| Low | 0.0475 on 09/06/22 | 14.16 on 12/05/25 | 115.59 on 12/09/25 | 299.50 on 12/16/25 | 455.63 on 01/20/26 |
| High | 0.4659 on 06/07/22 | 18.82 on 02/23/26 | 132.49 on 02/12/26 | 372.73 on 02/24/26 | 537.19 on 02/25/26 |
| 6-Month | |||||
| %Chg | -93.21% since 03/04/22 | +26.18% since 08/27/25 | -15.62% since 08/27/25 | +5.61% since 08/27/25 | +65.03% since 08/27/25 |
| Low | 0.0475 on 09/06/22 | 12.99 on 10/30/25 | 115.25 on 11/19/25 | 295.22 on 08/28/25 | 302.19 on 08/28/25 |
| High | 3.9400 on 04/20/22 | 18.82 on 02/23/26 | 156.49 on 08/29/25 | 385.22 on 11/17/25 | 537.19 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,471 | 59,662,048 | 55,340,980 | 34,762,076 | 22,084,924 |
| Shares Outstanding, K | 52,021 | 3,181,976 | 422,128 | 109,663 | 43,828 |
| Annual Sales | 13,960,000 | 30,238,240,000 | 9,467,000,000 | 3,810,240,000 | 2,877,400,000 |
| Annual Net Income | -40,620,000 | 712,320,000 | 2,673,000,000 | -644,790,000 | 1,195,100,000 |
| Last Quarter Sales | 4,050,000 | 7,736,500,000 | 2,387,000,000 | 1,412,280,000 | 799,500,000 |
| Last Quarter Net Income | -10,690,000 | 672,830,000 | 603,000,000 | 124,840,000 | 338,700,000 |
| 60-Month Beta | 1.96 | 0.02 | 0.96 | 0.52 | 0.85 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/18/22 | 0.44 on 10/30/25 | 1.48 on 02/12/26 | 1.95 on 02/26/26 | 7.70 on 02/25/26 |
| Latest Earnings Date | 11/17/22 | 05/14/26 | 05/05/26 | 05/06/26 | 04/29/26 |
| Most Recent Dividend | N/A | 0.252 on 09/30/25 | 0.530 on 01/20/26 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 09/30/25 | 04/20/26 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.72 | 20.42 | 84.98 | 18.06 |